North America

Thu
31
Jan

Study: CBD-dominant cannabis oil safe and effective in autistic patients

The administration of plant-derived cannabis extracts is effective and well-tolerated in patients diagnosed with autism spectrum disorders (ASD), according to data published in the journal Scientific Reports.

Thu
31
Jan

Is Canopy Growth Corp (TSX:WEED) about to be dethroned?

It’s an exciting time for the cannabis industry. After sustaining heavy losses in the second half of last year, marijuana stocks are back and kicking, with Canopy Growth Corp (TSX:WEED)(NYSE:CGC) having gained 63% in the first 25 days of January.

Thu
31
Jan

This silly fight is pitting marijuana stocks against each other

Marijuana investing is back in the spotlight in 2019, with many major marijuana-production stocks seeing nice bounces after a tough showing last year. As interest in cannabis has grown, more and more companies have sought to profit from the craze, and that has led to companies making efforts to get their shares listed on public markets both on exchanges in Canada, as well as on major stock markets in the U.S. like the NYSE and Nasdaq.

Thu
31
Jan

Is going global the wrong move for cannabis stocks?

Many Canadian pot stocks have been fighting for positioning across the globe in the hopes of securing first-mover advantages in key countries. However, I’m not sure that is the correct strategy with so many opportunities in North America alone.

While pot sales totaled $54 million in November, in what was the first full month of recreational pot being legalized in Canada, supply issues have continued to plague the country. Sales weren’t all that impressive given how strong the numbers were in October with just two weeks of sales totaling $43 million. It’s therefore no surprise that a province like Prince Edward Island was able to claim the highest per capita sales in November, especially since Ontario and B.C. are nowhere near running at full capacity.

Thu
31
Jan

Will the Canadian medical cannabis market survive?

Quarterly earnings results covering the post-recreational-marijuana-legalization period in Canada will flood the media in February, allowing the market to assess the performance of the industry players and to somehow refine expectations for the local cannabis market and the seemingly weakening medical cannabis segment.

High revenue-growth rates are backed into anything marijuana related today, as the nascent adult-use market is expected to catapult revenues and earnings for the pot industry going forward, but lower wholesale prices and excise taxes are hurting margins, yet the medical cannabis segment affords licensed producers (LPs) the opportunity to capture the full retail margins through direct sales to clients.

Thu
31
Jan

One winner of Sunday's Super Bowl: the marijuana industry Cannabis

Come Sunday night, the Super Bowl will have its winner and its loser.

But before the two teams even made it to Atlanta, the country’s annual circus of consumerism and commercialism already had one clear victor: the marijuana industry.

CBS’s refusal to run a cannabis-focused investment firm’s ad advocating for the legalization of medical cannabis marked a coup for an industry whose product is still illegal federally. “The fact that an ad was even considered for the Super Bowl shows that we’ve turned a corner,” Lisa Buffo, the founder of the Cannabis Marketing Association, told the Guardian.

Thu
31
Jan

Clearing the air on cannabis cultivation

As the cannabis sector continues to grow in Canada, so do questions about worker health and safety. One area of particular concern is air quality.

There is a propensity for mould and bacteria to thrive in greenhouses and grow houses. Cannabis typically grows in temperatures between 21 C and 32 C, with relative humidity higher than normal humidity levels, which are 40 percent to 50 percent for health and comfort.

 

“These are good conditions for mould growth,” suggests Janet Deline, media spokesperson for Ontario’s Ministry of Labour in Toronto.

Wed
30
Jan

Where the green is: Cannabis jobs

 

Here's some good news about the labor market: The cannabis industry is creating jobs at a rapid pace, a new study from employment site Glassdoor finds.

 

 

 

Wed
30
Jan

Canopy Growth-backed Slang to debut with $500-million market value

Two cannabis entrepreneurs who sold their first pot company to Canopy Growth Corp. for $430 million (US$324 million) may hit pay dirt again when they take their cannabis brand company public.

Slang Worldwide Inc., co-founded by Peter Miller and Billy Levy, begins trading at $1.50 a share Tuesday on the Canadian Securities Exchange for a market value of about $500 million, according to a company representative. That would be more valuable than Mettrum Health Corp. when Miller and Levy sold it in early 2017 to Canopy, the world’s largest cannabis company.

Wed
30
Jan

U.S. Funds with $100 billion explore loans to Canadian pot firms

Large U.S. funds are exploring lending to Canadian cannabis companies as a way to gain expertise in the burgeoning market ahead of potential U.S. legalization, according to an investment banker who’s been holding weekly calls with the firms.

Funds with $100 billion or more in assets under management are considering issuing loans to mid-tier marijuana producers, said Alfred Avanessy, managing director at Toronto-based brokerage Cormark Securities Inc., which offers cannabis investment banking, advisory and research. At least three other people at other financial services firms have been approached by the funds regarding cannabis lending. All declined to name the potential investors as the talks are preliminary.

Pages

Subscribe to RSS - North America